JPRN-UMIN000008318招募中2 期
Effect of additional aprepitant on palonosetron and dexamethasone for prevention of moderately emetogenic chemotherapy-induced nausea and vomiting in patients with lung cancer: clinical phase II study - Effect of additional aprepitant on palonosetron and dexamethasone for prevention of moderately emetogenic chemotherapy-induced nausea and vomiting in patients with lung cancer: clinical phase II study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)vomiting within 24h before first chemotherapy 2)continuatory use of severely or moderately emetogenic anticancer drugs after Day 2 3)concurrent radiotherapy 4) Severe complications 5)Symptomatic brain meta 6)Hypersensitivity for PaIonosetron, Aprepitant, Dexamethasone 7) Other patients who are unfit for the study as determined by the attending physician.
研究者
相似试验
已完成
不适用
The effect of combination of palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in women patients using intravenous patient-controlled analgesia: combination of palonosetron and aprepitant vs palonosetron alone.KCT0002433Soon Chun Hyang University Hospital Seoul100
已完成
不适用
Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II studycervical cancerJPRN-UMIN000011616Chiba University Hospital20
已完成
不适用
The effect of Palonosetron for the prevention of postoperative nausea and vomitingKCT0000581Soon Chun Hyang University Hospital Seoul214
已完成
不适用
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer.cervical cancerJPRN-UMIN000007638chiba university25
已完成
不适用
Comparison of the effects of palonosetron and ramosetron mixed with intravenous patient-controlled analgesia infusion fluidKCT0004834Inje University Haeundae Paik Hospital114